Výsledky vyhledávání - "Kristen Striffler"

OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use

Autor: Alice T Epitropoulos, Sheraz M Daya, Cynthia Matossian, Alan G Kabat, Gretchen Blemker, Kristen Striffler, Laura Hendrix, Marian Macsai, Andrea Gibson

Publikováno v: Clinical Ophthalmology. 16:3405-3413

Alice T Epitropoulos,1,2 Sheraz M Daya,3 Cynthia Matossian,4 Alan G Kabat,5,6 Gretchen Blemker,5 Kristen Striffler,5 Laura Hendrix,5 Marian Macsai,5 Andrea Gibson5 1Ophthalmic Surgeons & Consultants of Ohio, the Eye Center of Columbus, Columbus, OH,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba84a3073c0cd8ab07ff008b149a411
https://doi.org/10.2147/opth.s383091

Zobrazit plný text záznamu

Plný text ve formátu HTML

Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial

Autor: Gail L, Torkildsen, Guruprasad R, Pattar, Gary, Jerkins, Kristen, Striffler, Jeffrey, Nau

Publikováno v: Clinical Therapeutics. 44:1178-1186

Dry eye disease is a multifactorial disorder that affects the ocular surface, with symptoms including ocular irritation, impaired vision, and pain. Nicotinic acetylcholine receptor (nAChR) agonists are novel treatments for dry eye disease; this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f89f2f889e58b603271deb672d5e9b5
https://doi.org/10.1016/j.clinthera.2022.07.006

Zobrazit plný text záznamu

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial

Autor: David, Wirta, Patrick, Vollmer, James, Paauw, Kuei-Hsun, Chiu, Eugenia, Henry, Kristen, Striffler, Jeffrey, Nau, Eva, Liang

Publikováno v: Ophthalmology. 129(4)

To evaluate the efficacy and safety of OC-01 (varenicline solution) nasal spray for treatment of patients with dry eye disease.Randomized, multicenter, double-masked, vehicle-controlled, phase 3 study.Adults 22 years of age or older with a diagnosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::73e9606c7bd13a2730635b97a835cd27
https://pubmed.ncbi.nlm.nih.gov/34767866

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání